Affimed N.V. (AFMDQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.000099 (9,900.00%)
At close: Jun 5, 2026
Affimed Market Cap
Affimed has a market cap or net worth of $1.64 thousand as of June 8, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
1.64K
Enterprise Value
n/a
Revenue
6.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 12, 2014, Affimed's market cap has decreased from 136.71M to 1.64K, a decrease of -100.00%. That is a compound annual growth rate of -61.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.64K | - |
| Dec 31, 2025 | 1.64K | -99.99% |
| Dec 31, 2024 | 19.51M | -79.10% |
| Dec 29, 2023 | 93.34M | -49.60% |
| Dec 30, 2022 | 185.18M | -72.75% |
| Dec 31, 2021 | 679.50M | 18.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rebus Holdings | 3.21K |
| OncoVista Innovative Therapies | 2.36K |
| Suvanza Pharma, LLC | 2.24K |
| ZIM Corporation | 1.63K |
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| TetraLogic Pharmaceuticals | 973.00 |